Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

Autor: Zhu, Dalong, Gan, Shenglian, Liu, Yu, Ma, Jianhua, Dong, Xiaolin, Song, Weihong, Zeng, Jiao'e, Wang, Guixia, Zhao, Wenjuan, Zhang, Qiu, Li, Yukun, Fang, Hui, Lv, Xiaofeng, Shi, Yongquan, Tian, Haoming, Ji, Linong, Gao, Xin, Zhang, Lihui, Bao, Yuqian, Lei, Minxiang, Li, Ling, Zeng, Longyi, Li, Xiaoying, Hou, Xinghua, Zhao, Yu, Hu, Tianxin, Ge, Xiaoyun, Zhao, Guiyu, Li, Yongguo, Zhang, Yi, Chen, Li
Zdroj: In The Lancet Diabetes & Endocrinology August 2018 6(8):627-636
Databáze: ScienceDirect